The results of the study from Lee et al. [98] suggest that upregulation of FGF21 due to CPTII deficiency is part of a systemic hormetic response, which protects mice from HFD-induced obesity and glucose intolerance. The gene discussed is FGF21; the disease is obesity disorder.